In April 2024, VKEY-BIO successfully passed the ISO9001 Quality Management System Certification and obtained the GB/T 19001-2016/ISO9001:2015 Quality Management System Certification. The scope of certification: Research and development, production and sales of detection reagents for research (reporter gene detection reagents, cell viability detection reagents, and TR-FRET reagents). This achievement marks a significant step forward for VKEY-BIO in the standardization, normalization, and scientific management of its quality management system.
During the audit, the expert panel conducted a comprehensive evaluation and assessment of various quality management processes within the enterprise through on-site inspections, personnel interviews, and document reviews, gaining a detailed understanding of the company's quality management operations. They provided full affirmation of our quality management and offered professional guidance.
The ISO9001 quality management system certification is a globally recognized standard for quality management. The successful passage of this ISO9001 certification is a full recognition of the existing quality management system at VKEY-BIO and serves as an impetus for the company's future development. Additionally, VKEY-BIO has also obtained certifications such as the Enterprise Credit Rating Certificate, Honesty Management Demonstration Unit Certificate, Honest Supplier Rating Certificate, Credit Unit Certificate, and Credit Rating Certificate. VKEY-BIO will take this as an opportunity to continuously optimize and improve its quality management system, providing customers with higher quality products and services to meet the needs and expectations of customers and the market.
About VKEY-BIO
VKEY-BIO, founded in 2019, is a biotechnology company dedicated to the research and production of reagents for life sciences. Recognized as a "High-Tech Enterprise," an "Innovative SME," and a "Technology-Based SME" in China, our focus is on providing high-quality reagents. Our mission is to contribute to the reduction of drug discovery costs by offering comprehensive and customized solutions for your research.
Our products primarily based on Luminescent and TR-FRET technology platforms, designed for drugs screening and validation purposes. Notably, our independently developed KeyTec® TR-FRET technology employs the stable energy donor (Solar Eu/Tb) and the stable energy acceptor (LA/HX) in a time-resolved fluorescence resonance energy transfer system. TR-FRET is known for its ease of use, homogeneity (no wash), low background, wide range and robustness. Furthermore, our independently developed KeyTec® Luminescent is known for its high sensitivity and robust luminescence. We eagerly anticipate the opportunity to collaborate with you, fostering advancements in life science research together.
English
